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We present a comprehensive study of the application of photon
time-of-ﬂight spectroscopy (PTOFS) in the wavelength range 1050–
1350 nm as a spectroscopic technique for the evaluation of the
chemical composition and structural properties of pharmaceutical
tablets. PTOFS is compared to transmission near-infrared spec-
troscopy (NIRS). In contrast to transmission NIRS, PTOFS is
capable of directly and independently determining the absorption
and reduced scattering coefﬁcients of the medium. Chemometric
models were built on the evaluated absorption spectra for
predicting tablet drug concentration. Results are compared to
corresponding predictions built on transmission NIRS measure-
ments. The predictive ability of PTOFS and transmission NIRS is
comparable when models are based on uniformly distributed tablet
sets. For non-uniform distribution of tablets based on particle sizes,
the prediction ability of PTOFS is better than that of transmission
NIRS. Analysis of reduced scattering spectra shows that PTOFS is
able to characterize tablet microstructure and manufacturing
process parameters. In contrast to the chemometric pseudo-
variables provided by transmission NIRS, PTOFS provides physi-
cally meaningful quantities such as scattering strength and slope of
particle size. The ability of PTOFS to quantify the reduced
scattering spectra, together with its robustness in predicting drug
content, makes it suitable for such evaluations in the pharmaceu-
tical industry.
Index Headings: Spectroscopy; Scattering measurements; Turbid
media; Multiple scattering; Spectroscopy, condensed matter.
INTRODUCTION
The manufacturing process of pharmaceutical materi-
als involves high-quality requirements to ensure efﬁ-
ciency and patient safety. Process analytical technology
has been deﬁned by the United States Food and Drug
Administration as a mechanism to design, analyze, and
control pharmaceutical manufacturing processes.1 Near-
infrared spectroscopy (NIRS) is a powerful spectroscopic
technique widely employed in the pharmaceutical
industry to monitor different stages of the production
process and to analyze the ﬁnal products.2–5 Since its
successful online implementation by major pharmaceu-
tical companies, NIRS has been widely used in critical
stages of the pharmaceutical process for the character-
ization of raw materials, drying, blending, and tableting.6
Near-infrared spectroscopy allows relatively cheap,
rapid, easy, and non-destructive measurements, without
the need for sample preparation.7 Its analytical power
has been demonstrated in a number of qualitative and
quantitative pharmaceutical applications.8 Chemometric
methods have been applied to NIR spectroscopic data by
the pharmaceutical industry to determine drug contents,9
polymorphic content,10 and particle sizes of powders.11,12
The key challenge in NIRS is to develop methods that
not only are accurate enough to determine analytical
parameters, such as content uniformity between different
tablets, but also have an inherent robustness such that
the prediction of concentration is insensitive to varia-
tions in, e.g., raw material particle size and batch
quality.13 The inherent high correlation of spectral
shapes and thus difﬁculty and inability to distinguish
the contributions from such parameters in NIRS spec-
tra14,15 require the development and maintenance of
extensive calibration databases. NIRS transmission
spectra depend on both the structural and chemical
properties of the medium. Elastic scattering of near-
infrared light in a pharmaceutical tablet dominates over
absorption by several orders of magnitude. Thus, the NIR
spectra are strongly susceptible to parameters related to
light scattering. This makes independent determination
of particle size of major importance.16 Abrahamsson et
al. have shown that predictions based on NIRS data were
improved by correcting for scattering effects in the
measured spectra.17 A method that is insensitive to
variations in the scattering properties of the medium is
highly desirable. It is widely recognized18 that reduced
scattering coefﬁcient can be signiﬁcantly changed by
variation in microstructure of turbid media. To correct for
the inﬂuence of structural properties, NIR transmission
spectra normally have to be preprocessed before they
can be analyzed.19,20
Photon time-of-ﬂight spectroscopy (PTOFS)17 is a
spectroscopic technique in which the temporal distribu-
tion of photon propagation times through samples is
measured. It provides less interdependent information
on reduced scattering (inﬂuenced by the structural
properties) and absorption (inﬂuenced by the chemical
composition) of a turbid medium. PTOFS is becoming
increasingly popular in broadband instruments.21–23 The
technique has been used speciﬁcally for the inspection
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of tablets24–26 and powders.27 Khoptyar et al.26 have
recently shown feasibility of spectroscopic evaluation of
tablet concentration on the basis of their PTOFS
absorption spectra. Because of the small number of
investigated tablets, it was impossible to consider
robustness of the technique and its sensitivity to large
scattering variation due in part to varying scatterer size
and different tablet compaction force. So far, little has
been done to systemically study the potential and
limitations of the new generation of broadband PTOFS
system for tablet spectroscopic analysis.
In this paper, we demonstrate that PTOFS provides a
valuable addition to spectroscopic analysis of pharma-
ceuticals in the wavelength range 1050–1350 nm. Broad-
band PTOFS was applied in a comprehensive study of 75
tablets in which the drug concentration, ﬁller, and API
particle size and compression force were varied. The
ability of PTOFS to measure drug concentration was
investigated in terms of the prediction ability. The results
obtained were compared to those obtained with contin-
uous-wave, transmission NIRS. The robustness of
PTOFS toward particle size variation is investigated
and compared to transmission NIRS. Finally, it is shown
that PTOFS reduced scattering spectra can be used to
determine particle form, size, and compression force,
without a chemometric calibration model.
MATERIALS AND METHODS
Materials. The 75 tablets used in this study were
composed from three components: mannitol, ibuprofen,
and magnesium stearate. The active pharmaceutical
ingredient (API) in the tablets was ibuprofen, and
mannitol was used as the ﬁller. Magnesium stearate is
a lubricant added to facilitate tablet compression. The
tablets were made by mixing the ingredients according
to the experimental design shown in Fig. 1. The
experiment was designed to investigate individual and
interdependent variation by varying the following factors:
ﬁller particle size (FPS), API particle size, API concen-
tration, and ﬁller particle manufacturing method. The
complete set of combinations consists of 23 unique
samples, denoted 1 to 23, spanning a wide range of
material compositions. The FPSs (mass median diame-
ter) used in the design were 91, 211, and 450 lm,
respectively.28 The average particle diameters of ibu-
profen used in the design were 71, 95, and 154 lm,
respectively, and the average concentration was varied
at ﬁve levels; 16, 18, 20, 22, and 24 (%w/w), respectively.
Properties for different ﬁller sizes and the manufacturing
methods are presented in Table I.
All the tablets were pressed with a single punch press
(Korsch EK 0, Korsch AG, Berlin, Germany) equipped
with ﬂat, round 10 mm punches. The compression force
(CF) was set manually to 8, 12, and 16 kN denoted CF1,
CF2, and CF3, respectively, for all powder blends
resulting in 3323 different tablet types (batches).
Single-component tablets were compressed in a manual
tablet press (Specac, Oprington, UK) using a CF of
approximately 20 kN. All tablets had a uniform diameter
of 10 mm, with a thickness of 3 mm and weight of
300 mg. The tablets were manufactured at AstraZeneca
R&D Mo¨lndal, Sweden, for another study.29
Transmission Near-Infrared Spectroscopy. Trans-
mission NIRS spectra were recorded for all the tablets
using a Fourier transform NIR spectrometer (MB160,
ABB-Bomem Inc., Canada), in transmission mode.29 The
spectra were recorded as the average of 32 scans for
each tablet, and the resolution was set to 16 cm1
corresponding to 2 nm at 1200 nm. For a more direct
comparison between transmission NIRS and PTOFS the
wavelength region from 1050 to 1350 nm was used. For
comparative study, the API concentrations in the
samples were determined using Raman spectroscopy.29
FIG. 1. Overview of the experimental design of the study. The upper section shows the various particle sizes, and the lower shaded section the
variation in API concentration. The red rectangle indicates tablets with the center points introduced for the factors studied. Here 1–23 denote the
combinations of factors.
TABLE I. Properties of the different ﬁller particle sizes (FPSs).28
Particle size (lm) Method BD (g/ml) Comp. (%)
FPS1 (91) Spray dried 0.57 6.9
FPS2 (450) Granular 0.71 4.5
FPS3 (211) Spray dried 0.50 9.9
BD = bulk density; Comp. = compressibility.
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Photon Time-of-Flight Near-Infrared Spectroscopy.
In PTOFS, the time-distribution of photons transmitted
through a sample is evaluated with picosecond time
resolution. A schematic of the PTOFS system is shown in
Fig. 2. A photonic crystal ﬁber supercontinuum source
(SuperK Extreme EXW 12, NKT Photonics A/S, Birkerød,
Denmark) was used in combination with an AOTF
(SuperK Select, NKT 384 Photonics A/S, Birkerød, Den-
mark) to generate tunable probe pulses with which to
irradiate the tablet. A small fraction of the pulse power is
split off prior to the sample and routed directly to the
detector for timing reference to increase measurement
accuracy.26 A photomultiplier tube (Hamamatsu, model
R3809U-68) is used for detection. The signal is fed to a
time-correlated single-photon counting (TCSPC) elec-
tronics (Becker&Hickl, model SPC-130) for high-preci-
sion measurements of the PTOF distribution.26 Data
acquisition is carried out using an automated measure-
ment sequence implemented in C#. The measurement
routine involves setting up the TCSPC module and
setting the wavelength and amplitude of the light source.
The attenuation of the light intensity through samples
was adjusted to obtain a count rate up to 50 kHz during
data acquisition. A total photon count of more than
50 000 was considered sufﬁcient for each data point,
yielding a recording time of 30 s per measurement.
Tablet spectra were scanned in the spectral range 950–
1400 nm with 4 nm resolution. The sequence in which
tablets were investigated was also randomized in order
to avoid any bias.
The shape of the PTOF distribution is affected by the
absorption and scattering of light, which are directly
inﬂuenced by the chemical and structural composition of
the medium. The optical properties, i.e., absorption and
reduced scattering, were evaluated from the PTOF
distribution at each wavelength with Matlab, using a
Levenberg–Marquardt-based ﬁtting algorithm with the
diffusion approximation model developed by Contini and
Martelli et al.30 Black-printed ofﬁce paper is used as a
sample to get instrument response function.21 The
instrument response function was in all subsequent
evaluations convolved with the ﬁtted diffusion model to
take into account the light dispersion in the optical ﬁbers
and ﬁnite detector response time. The estimated absorp-
tion coefﬁcient, la, is normally used for the analysis of the
chemical constituents and the composition of the tablet.
The reduced scattering coefﬁcient, l0s = ls(1g), is
generally correlated to the structural properties, where
ls is scattering and g is called the anisotropy of the
medium.
The signal-to-noise ratio (SNR) for both transmission
NIRS and PTOFS was calculated by ﬁtting a polynomial
to a section of each spectrum, using the expression:
SNR ¼ mean spectrajPolynomial fit spectra j
 
ð1Þ
DATA ANALYSIS
Multivariate regression analysis31 was performed
using partial least squares regression32 to predict the
API concentrations from transmission NIRS and PTOF
spectra, respectively. Calibration models for the API
content were constructed by dividing the data into
calibration and validation sets. Group-fold cross-valida-
tion32 and manual selection were used to determine the
number of latent variables in the calibrations models.
The calibrations were then applied to the validation set
to predict the API concentration. In the ﬁrst case, 70% of
the samples were randomly chosen as the calibration
set, and the remaining 30% served as the validation set.
In the second case, the data were divided based on the
average particle size of the tablets.
Analysis of Transmission Near-Infrared Spectra.
Near-infrared spectra often require pretreatment for
underlying scattering signal.19 The effect of difference
in particle sizes on TNIRS spectra is quantitatively the
most important. It can partly be corrected using mean
centered data,31 derivatives,33 multiplicative scatter
correction (MSC),34 or standard normal variate.35 We
used MSC for the preprocessing of the transmission
NIRS spectra.
Analysis of Photon Time-of-Flight Data. The PTOFS
technique provided spectra of absorption and reduced
scattering as described above. Principal component
analysis (PCA) was used in evaluating the absorption
spectra, as this provides the most compact orthogonal
description of the data.31 Reduced scattering spectra
were modeled with an approximation from Lorentz–Mie
theory as explained later.
RESULTS AND DISCUSSION
Measurement Stability and Noise. Bias-variance
tests were carried out to determine the stability of the
PTOFS system. Figure 3a shows the absorption coefﬁ-
cients of a tablet estimated at three wavelengths close to
FIG. 2. Schematic showing the set up used for PTOFS. AOTF: acousto-optical tunable ﬁlter; PMT: photomultiplier tube; TI Amp: transimpedance
ampliﬁer; TCSPC card: time-correlated single-photon counting card.
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the absorption peak, as a function of data acquisition
time. Error bars are the result of repetitive measure-
ments. The acquisition time for the PTOF distribution was
varied in these measurements between 0.5 and 8 s at
each wavelength. The evaluated absorption for each
measurement is within the standard deviation (SD) from
the mean of all measurements at that wavelength. The
absorption coefﬁcients obtained are constant within 1%,
showing that no bias was introduced by altering the
acquisition time. Similar tests were performed to check
the variation in the distribution of ingredients inside the
tablets. A tablet was measured twice from both sides,
and the system showed reliable and reproducible
results, as can be seen in Fig. 3b.
Evaluated Absorption and Active Pharmaceutical
Ingredient Concentrations. Absorbance and absorption
spectra from both the transmission NIRS and PTOFS
technique are presented in Fig. 4a and 4b, respectively.
The transmission NIRS attenuation spectra are plotted in
the same wavelength range as the PTOFS spectra, and it
can be seen that there is, in general, good agreement
between the two methods. The inﬂuence of the scattering
properties of the samples can be visualized by a
prominent offset shift in the transmission NIRS spectra.
The SNR, calculated from Eq. 1, was more than 10 times
higher in the transmission NIRS spectra than in the
PTOFS spectra. Spectra of pure ingredients are also
shown in Fig. 4b, which indicates an overlap of mannitol
and ibuprofen spectra at 1200 nm.
Figure 5 shows the scatter plot resulting from the PCA
applied to PTOFS absorption spectra for the ﬁrst two
principal components. Ideally separated absorption
spectra from reduced scattering spectra will not show
any inﬂuence from the particle size. If labeled for an
uncompressed FPS, no data grouping will be observed.
However, the scatter plot shows that tablets with larger
ﬁller particles cluster separately from the others,
indicating that absorption is not completely separated
from reduced scattering. This correlation can be ex-
plained by the crosstalk between the optical properties36
and requires further investigation. For the PTOFS data
the ﬁrst two principal components explain more than
80% of the variance. The results of PCA also suggested
that the wavelength region between 1050 and 1350 nm
FIG. 3. Estimated absorption coefﬁcient, la, as a function of the data acquisition time of the PTOFS distribution. (a) Bias-variance test and (b) test
for uniform ingredient distribution by measuring on both sides of a tablet. The error bars indicate the SD from three measurements. Mean values for
each wavelength are also plotted.
FIG. 4. (a) Transmission NIRS absorbance spectra for all 75 mixed tablets and (b) PTOFS absorption spectra for all pure and mixed tablets. The
dashed vertical lines indicate 1050–1350 nm used for analysis. The signal-to-noise ratio (SNR) is given in each case.
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was suitable for prediction of API content since the
variation in concentration could be clearly seen in the
ﬁrst principal component.
To predict the API concentrations from both transmis-
sion NIRS and PTOFS spectra, partial least squares
regression was used, relating the variance to the desired
output. The prediction is achieved by extracting a set of
orthogonal factors called latent variables from the
predictors (wavelengths) that have the best predictive
power. The contribution toward variance by predictors
for each latent variable is called loading, which can
explain how variance may relate to the predictions.
Loadings of the ﬁrst six latent variables of partial least
squares for transmission NIRS and PTOFS spectra are
shown in Fig. 6a and 6b, respectively. Out of those six,
physically meaningful information is contained in only
two for transmission NIRS and four for PTOFS. In the
case of transmission NIRS, two latent variables are
necessary to describe ibuprofen concentrations. For
PTOFS, not only ibuprofen concentration and mannitol
amplitude is explained, but the crosstalk by scattering as
well is captured, requiring comparatively complex
models (four variables). Therefore, two and four latent
variables are used for transmission NIRS and PTOFS
predictions, respectively.
Predictive models are built on tablets in a calibration
set and then validated on tablets in a validation set.
Tablet data are ﬁrst split into 70–30% sets for calibration
and validation, respectively. The prediction performance
was then compared to well-structured classiﬁcation of
data. Table II presents the average results of a 100
random set of calibration and validation samples. Ratio
of performance to deviation (RPD) is a measure of the
usefulness of models, and a value more than three is
considered useful for screening.37 Four latent variables
for the PTOFS data produced RPD = 3 and root mean
square error of prediction,38 RMSEP = 0.92. These
should be compared with RPD = 2.77 and RMSEP = 1.03
when using two latent variables for the transmission
NIRS data. Variance explained by latent variables (R2) in
both cases is comparable. The reasons for PTOFS higher
model complexity are the inherent sparseness of the
experimental design of the tablet data set and the
crosstalk between optical properties.
To compare the robustness of the two techniques the
models are challenged by selecting a validation set
based on different FPSs than those of the calibration set.
The purpose of challenging the models in this way is to
see if PTOFS is less sensitive toward variations in raw
material than transmission NIRS. Table III presents the
prediction results. The models were calibrated using
data sets with large FPS, and the predictions were
validated on data sets with a small FPS. Model
complexities are kept similar to the previous case.
Compared to results in Table II, models based on PTOFS
spectra improved the RPD value to 3.42 and reduced the
RMSEP to 0.84. Models on transmission NIRS data,
however, showed higher sensitivity to variations in
particle sizes, thus making predictions more difﬁcult.
The difference in RMSEP values for transmission NIRS
(1.12) and PTOFS (0.84) is statistically signiﬁcant.
The prediction accuracy of both techniques is
comparable when the models are based on uniformly
distributed particle sizes. However, when the models
are based on the data set using one particle size and
the predictions are made for different particle sizes,
the prediction error for PTOFS is smaller than that with
transmission NIRS. PTOFS thus showed less sensitiv-
ity to the variations in raw ﬁller material than
transmission NIRS. It can therefore be concluded that
the analysis using PTOFS is more robust toward
changes in particle sizes.
FIG. 5. PCA scatter plot for tablets with different FPSs (before
compression) on the ﬁrst two principal components (PC) for PTOFS
absorption spectra. The dashed ellipse indicates 95% conﬁdence
interval.
FIG. 6. Loadings of the ﬁrst six latent variables of partial least squares for (a) transmission NIRS data and (b) PTOFS data.
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Photon Time-of-Flight Spectroscopy Reduced Scat-
tering. Figure 7 presents PTOFS reduced scattering
spectra for pure ingredients and mixed tablets, respec-
tively. Although the absorption and reduced scattering
have different origins, they are often correlated36 due to
crosstalk as a result of ﬁnite bandwidth, modeling
inaccuracies, or data-gathering procedures. The re-
duced scattering spectra from mixed tablets indicate a
correlation with absorption peaks around 1200 nm and
after 1350 nm (see Fig. 4). All the mixed tablets exhibit
higher wavelength dependence of the scattering slope
and scattering amplitudes than ibuprofen and magne-
sium stearate. This indicates that mannitol is mainly
responsible for scattering inside the mixed tablets. The
reduced scattering coefﬁcient is deﬁned as39
l0s ¼ qQs
pd2
4
ð1 gÞ ð2Þ
where q is the average particle number density, Qs is
size-dependent scattering efficiency of the particle, d is
diameter of the scatterer, and g is the anisotropy of the
medium. The scattering efficiency Qs tends to approach a
value of 2 for large pure scatterers, for pd/k  1, where
k is the wavelength of the light. The empirically observed
scattering behavior for small and intermediate sized
particles is relatively well modeled using Rayleigh and
Mie theories:40
l0s ¼ Aðk=k0Þb ð3Þ
Equation 3 is a relatively good approximation for
scattering behavior of pharmaceuticals in the NIR
spectral regime. A is the reduced scattering coefﬁcient
at the reference wavelength k0, and b is the slope of the
ﬁt versus wavelength. For Rayleigh scattering, the size
parameter, pd/k, is much less than 1, and the scattering
is dependent on k4. For larger particles than the
Rayleigh limit, b varies from 4 to 0 depending on the
size parameter. The large particle limit is b = 0, where
Qs = 2. At such size parameters l0s will be independent
of wavelength. According to Lorentz–Mie scattering
calculations, the ﬁller particles would approach this limit
for all three FPSs. However, the reduced scattering of
mannitol is highly dependent on wavelength, indicating
an effective size parameter being much smaller than for
the original mannitol particles used for the production of
the tablets. Figure 8 shows scanning electron microsco-
py images of original ﬁller particles with three different
FPS used in the tablets, where it can be seen that they
TABLE II. Results of partial least squares regression using group-fold cross-validation for API concentration prediction from transmission
NIRS and PTOFS data. The average values over 100 runs are given for the random 70–30% split of the data. The same spectral region, 1050–
1350 nm, was considered for both techniques.a
Method Cal. set (%) Val. set (%) Pretreat. LVs R2 cal. R2 pred. RMSEC RMSEP SD RPD
Transmission NIRS 70 30 MSCþmean centered 2 0.92 0.81 0.83 1.03 0.34 2.77
PTOFS 70 30 Mean centered 4 0.92 0.88 0.81 0.92 0.12 3.00
a Cal. = calibration; Val. = validation; Pretreat. = pretreatment; LVs = latent variables; R2 = Variance explained; RMSEC = root mean square error
of calibration; RMSEP = root mean square error of prediction; SD = standard deviation; RPD = ratio of performance to deviation.
TABLE III. Results of partial least squares regression using group-fold cross-validation for API concentration prediction from transmission
NIRS and PTOFS data. Model generalization tested on structured selection of calibration and validation sets based on average particle sizes.
Method Cal. set Val. set Pretreat. LVs R2 cal. R2 pred. RMSEC RMSEP SD RPD
Transmission NIRS Large particles Small particles MSCþmean centered 2 0.92 0.86 0.85 1.12 – 2.57
PTOFS Large particles Small particles Mean centered 4 0.93 0.90 0.77 0.84 – 3.42
FIG. 7. (a) Reduced scattering spectra (l0s ) for pure ingredients and (b) mixed tablets. The black curves are the predictions based on Eq. 3.
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are irregularly shaped and exhibit surface roughness.
When compression is applied to form a tablet, these
irregularities can lead to voids between surfaces that act
as scatterers.41,42 Compared to the original particles,
these voids are small enough to create wavelength-
dependent scattering of the light.
Effects of Filler Particle Size and Compression
Force. The scattering amplitude is plotted against the
scattering slope in Fig. 9 for three different compression
forces. The cluster of data for lower b values presents
tablets with FPS2 = 450 lm, clearly distinguishable from
FPS1 and FPS3, clustered at higher b values. This
illustrates the ability of PTOFS to directly differentiate
between FPS and CF.
To have a better visualization of different groups of
data, a relative scale image is presented in Fig. 10a.
Subtracting the ﬁtted equation for CF1 from all ﬁtted
equations gives a clear separation of groups on the y-
axis. Tablets with FPS2 = 450 lm are indicated by ﬁlled
symbols and FPS1 = 91 lm by open symbols; the green
stars show FPS3 = 211 lm. Using PCA provides a similar
way to explore these effects in transmission NIRS data.
Figure 10b shows the PCA scatter plot for transmission
NIRS data for ﬁrst two principal components, explaining
more than 98% variance (compared to 80% in the PTOFS
data; see Fig. 5). It is interesting that the tablets made
with FPS3 = 211 lm and FPS1 = 91 lm are located
together in both ﬁgures. The reason is believed to be the
smaller ﬁnal size of the ﬁller particles after tableting.
The compression force affects the internal structure of
the tablet depending on the properties of the particles.
Thus, particle size is not the only relevant factor; particle
density also affects scattering. Harder particles may not
collapse as easily as softer particles under an external
force. Larger particles, 450 lm, were made by granula-
tion while the smaller particles were spray dried. This
may explain why the tablets made with FPS3 = 211 lm
FIG. 8. Scanning electron microscopy images of ﬁller particles (mannitol) with sizes of (a) 91 lm, (b) 211 lm, and (c) 450 lm.
FIG. 9. Plot of A vs. b from Eq. 3. The solid lines are the linear ﬁts to data from tablets made with the same compression force (CF). Filled markers
represent FPS2 = 450 lm, and hollow markers represent FPS = 91 lm, except green stars, presenting FPS3 = 211 lm. Inset: Equations for solid
lines through each CF.
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particles coincide with the particle cluster representing
FPS1 = 91 lm.
Principal component analysis as applied to the
transmission NIRS data also shows a clear dependence
on FPS and compression force. However, to be able to
use this information in a productive manner, multivariate
data analysis techniques are required for interpretation
and predictions. The same information can easily be
obtained from the reduced scattering coefﬁcient of
PTOFS. The effects of the production method of ﬁller
particle, particle size after compression, and compres-
sion force used during tablet production are evident in
the wavelength dependence and amplitude of the PTOFS
scattering spectra. Measuring the reduced scattering
with PTOFS enables a direct relation to be established
between particle size and the coefﬁcient b. In this study,
we observed that as the FPS increases, the effects of the
compression force become less distinguishable. How-
ever, compression effects are well distinguished for
tablets with lower FPSs. PTOFS can directly differentiate
between ﬁller particles made with different manufactur-
ing processes.
CONCLUSIONS
A comprehensive study of pharmaceutical tablets has
been carried out in the close NIR spectral regime 1050–
1350 nm using PTOFS and the results compared to those
obtained with traditional transmission NIR spectroscopy.
Chemometric models were built to predict the ibuprofen
concentration from the PTOFS absorption spectra and
transmission NIRS spectra. Transmission NIRS and
PTOFS were found to have comparable prediction ability
when the models were based on uniformly distributed
data sets. When the models were trained on tablets with
larger ﬁller particle size and challenged with test sets
consisting of tablets with a smaller ﬁller particle size, the
prediction ability of transmission NIRS was signiﬁcantly
reduced. However, corresponding models based on
PTOFS data showed better prediction ability. Models
based on PTOFS absorption spectra for the prediction of
drug concentrations are less sensitive to variations in
ﬁller particle size, making PTOFS a comparatively robust
technique.
We showed that the amplitude and slope of reduced
scattering spectra not only distinguish between manu-
facturing processes of ﬁller material, but also charac-
terize the process parameters, like compression force.
PTOFS thus provides physically meaningful parameters
without chemometric models. Transmission NIRS, on the
other hand, provides chemometric pseudo-variables that
can be difﬁcult to interpret. The steep scattering slopes
observed suggest that scattering occurs from much
smaller scatterers than the original ﬁller particles and
that the observed tablet scattering spectra cannot be
directly explained by the original particle size of the
ingredients.
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